JP Despres - Current pharmaceutical design, 2009 - ingentaconnect.com Abstract: Abdominal obesity (high waist circumference) is more strongly
associated with cardiovascular disease and type 2 diabetes than generalized
adiposity (high body mass index). Recent research has highlighted the role ... Cited by 5 - Related articles - All 4 versions
B Le Foll, DA Gorelick, SR Goldberg - Psychopharmacology, 2009 - Springer Abstract Introduction Great interest has been shown by the medical community and
the public in the cannabinoid CB1 receptor antagonists, such as rimonabant, for
treatment of obesity, metabolic syndrome, and possibly drug addiction. ... Cited by 4 - Related articles - All 2 versions
- ►nih.gov P Pacher - Arteriosclerosis, thrombosis, and vascular biology, 2009 - Am Heart Assoc Clinical trials with rimonabant (the first CB 1 antagonist/inverse agonist)
approved in numerous European and other countries, for the treatment of obesity
and associated cardio-metabolic disorders) involving obese individuals with ... Cited by 3 - Related articles - All 7 versions
S Lecour - Journal of Molecular and Cellular Cardiology, 2009 - Elsevier Acute myocardial infarction is a burden disease that affects the population in
developed countries and is also of increasing concern to developing countries.
Coronary heart disease afflicts about 1.2 million Americans [1] every year ... Cited by 3 - Related articles - All 13 versions
A Viljoen, AS Wierzbicki - Current Drug Targets, 2009 - ingentaconnect.com Abstract: Hypertriglyceridaemia is associated with insulin resistance,
hypertension, obesity and diabetes. The manage- ment of hypertriglyceridaemia
and atherogenic dyslipidaemias increasingly involves the use of several ... Cited by 2 - Related articles - All 2 versions
S Choussein, AA Makri, CC Frangos, ET … - Diabetes, Obesity & Metabolism, 2009 - pt.wkhealth.com Obesity is considered as a major health problem, as its prevalence continuously
rises worldwide. One of the common health consequences of obesity is type 2
diabetes mellitus. Therefore, antiobesity management is a prerequisite in ... Cited by 2 - Related articles - All 6 versions
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last updated …
D Taylor - Current Drug Safety, 2009 - ingentaconnect.com In October 2008, the European Medicines Agency (EMEA) recommended the temporary
suspension of the marketing authorisation for rimonabant (Acomplia) because of
fears over the drug's association with psychiatric adverse effects [1]. ... Related articles - All 3 versions
G Terry - diss.kib.ki.se Page 1. Thesis for doctoral degree (Ph.D.) 2009 In Vivo Imaging of the Cannabinoid
CB 1 Receptor using Positron Emission Tomography Garth Terry ... Related articles
A Anderson, M Fisher, G McKay, GR … - Practical Diabetes International - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
